Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 10, 2017, 16:00 ET Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease

Vtesse, Inc., a company committed to developing medicines to benefit patients with ultra rare, life-threatening diseases, announced today that...


Jan 10, 2017, 10:00 ET Debiopharm International SA Announces Positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI Patients

Debiopharm International SA (Debiopharm - http://www.debiopharm.com), part of Debiopharm Group™, a Swiss-based global biopharmaceutical company,...


Jan 10, 2017, 10:00 ET Debiopharm International SA annonce une étude clinique de phase 2 positive portant sur le Debio 1450 chez des patients ABSSSI

L'étude menée auprès de patients atteints d'infections bactériennes aiguës de la peau et des structures cutanées (ABSSSI) causées par des...


Jan 10, 2017, 09:15 ET TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients

JACKSONVILLE, Fla., Jan. 10, 2017 /PRNewswire/-- TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the...


Jan 10, 2017, 09:10 ET ePatientFinder and Allscripts Launch GeoPrecise Solution, a Game-Changing Heatmap Tool for Clinical Trial Site Selection and Patient Identification

ePatientFinder®, the leader in EHR-driven clinical trial site optimization and patient identification, and Allscripts® announce the release...


Jan 10, 2017, 09:00 ET PROCEPT BioRobotics Completes Enrollment of Pivotal Clinical Trial for the Treatment of Benign Prostatic Hyperplasia

PROCEPT BioRobotics, a Silicon Valley robotics company developing intelligent surgical solutions to treat prostate disease, announced today the...


Jan 10, 2017, 07:10 ET NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke

Indianapolis Medical device maker NICO Corporation today announced the enrollment of the first patient in the ENRICH (Early MiNimally-invasive...


Jan 10, 2017, 06:00 ET Valeant Pharmaceuticals Announces Results Of Second Phase 3 Study For Psoriasis Treatment IDP-118

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced positive results from a second...


Jan 10, 2017, 01:30 ET ThromboGenics Enrolls First Patients in Phase II Clinical Study Evaluating THR-317 (Anti-PlGF) for Diabetic Macular Edema (DME)

THR-317 could become an attractive alternative or add-on treatment for current anti-VEGF medicines when treating DME or DR ThromboGenics...


Jan 09, 2017, 17:48 ET European Commission Ratifies Positive CHMP Opinion for the Renewal of Translarna™ Marketing Authorization for the Treatment of Nonsense Mutation Duchenne Muscular Dystrophy

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that it received notification today from the European Commission (EC) of its adoption of a positive...


Jan 09, 2017, 16:05 ET Halozyme Provides Program Updates, 2017 Financial Guidance At 35th Annual JP Morgan Healthcare Conference

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today provided program...


Jan 09, 2017, 13:00 ET NCCN Publishes Patient Education Resources for Gliomas--Its First in a Series on Brain Cancer

The National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients® and NCCN Quick Guide™ sheets for Brain Cancer –...


Jan 09, 2017, 10:19 ET Barbara Zupancic of Worldwide Clinical Trials to Present at SCOPE 2017

Barbara Zupancic, Director of Global Patient Recruitment and Retention at Worldwide Clinical Trials, will present at this year's Summit for...


Jan 09, 2017, 10:00 ET QIAGEN Submits QuantiFERON®-TB Gold Plus for U.S. Regulatory Approval

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the submission of QuantiFERON®-TB Gold Plus (QFT®-Plus), the fourth...


Jan 09, 2017, 09:57 ET TissueGene to Highlight Invossa™, the World's First Cell-Mediated Gene Therapy for Degenerative Osteoarthritis, at JP Morgan Healthcare Conference

TissueGene, Inc. ("TissueGene"), a Maryland-based regenerative medicine company, announced today that CEO Woosok Lee will present at the 35th...


Jan 09, 2017, 09:00 ET Angionetics Research Head Authors Scientific American Article on Therapeutic Angiogenesis as Potential New Treatment Approach for Ischemic Heart Disease

An article titled "Heart Therapy," written by Gabor M. Rubanyi, M.D., Ph.D., co-founder of Angionetics Inc., a majority-owned subsidiary of Taxus...


Jan 09, 2017, 09:00 ET Yiling Pharmaceuticals to Invest $20 Million in HealthWatch

HealthWatch, an Israeli company that has developed the world's first medical-grade smart clothing technology, announced today that Yiling...


Jan 09, 2017, 09:00 ET HEMA Biologics, LLC announced today the acceptance by U.S. Food and Drug Administration of the submitted Biologic License Application for Coagulation Factor VIIa Recombinant, (eptacog beta activated)

HEMA Biologics, LLC announced that the FDA has accepted the BLA for their first potential product for commercialization in the United States. The...


Jan 09, 2017, 09:00 ET Sorrento Subsidiary, SCILEX Pharmaceuticals, Announces Key Endpoints Met in the European Union Pivotal Bioequivalence Clinical Study for Its Lead Product, ZTlido™

SCILEX Pharmaceuticals Inc. ("SCILEX"), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") today announced that its pivotal...


Jan 09, 2017, 08:55 ET CartiHeal Performs First Clinical Cases with its New Unicondylar Implant

CartiHeal (2009) Ltd., developer of cell-free, off-the-shelf implants for use in cartilage and osteochondral defects, announced today that two...


Jan 09, 2017, 08:30 ET Aridis Pharmaceuticals Receives Award from the Cystic Fibrosis Foundation Therapeutics to Advance Panaecin™

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies...


Jan 09, 2017, 08:30 ET DelMar Pharmaceuticals Receives Additional Non-Dilutive Funding from the Government of Canada to Support Expanded Research with Lead Product Candidate VAL-083

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" and the "Company"), a biopharmaceutical company focused on the development and...


Jan 09, 2017, 08:03 ET Infinity Provides 2017 Goals and Financial Guidance

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today outlined anticipated milestones for IPI-549, a potentially first-in-class immuno-oncology...


Jan 09, 2017, 08:00 ET Galmed Pharmaceuticals Completes Patient Recruitment for ARREST Phase IIb NASH study

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of...


Jan 09, 2017, 08:00 ET Humana and Boehringer Ingelheim Report New Findings Suggesting Strategies for Improving COPD Medication Adherence

Humana Inc. (NYSE: HUM), one of the country's leading health and well-being companies, and Boehringer Ingelheim Pharmaceuticals Inc., a global...